Bioharvest Sciences, Inc. (TSE:BHSC) has released an update.
Bioharvest Sciences Inc., a biotech firm specializing in Botanical Synthesis technology, is set to host a webinar on March 13, where they will introduce their new CDMO business unit aimed at revolutionizing the sourcing of plant-based therapeutic molecules. This unit promises to offer industry leaders lower costs, faster development, and consistent manufacturing of next-generation molecules. The event will feature insights from the CEO and Chairman, who will discuss the unit’s potential to enhance the company’s IP library and business growth.
For further insights into TSE:BHSC stock, check out TipRanks’ Stock Analysis page.
